Example: Heart Attack

Search clinical trials for: Antibiotics, Antineoplastic

Total 4339 results

NCT04498793

Not yet recruiting

Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer

Conditions: HER2-negative Breast Cancer
NCT04493073

Not yet recruiting

Conjunctival Vascularity Changes Usnig OCTA After Trabeculectomy

Conditions: OCTA
NCT04493164

Not yet recruiting

CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Conditions: Acute Myeloid Leukemia; Acute Myeloid Leukemia With Gene Mutations; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia
NCT04490993

Active, not recruiting

Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients

Conditions: Non-muscle Invasive Bladder Cancer
NCT04488601

Not yet recruiting

Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study

Conditions: Aging
NCT04482712

Not yet recruiting

Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS

Conditions: Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS); Respiratory Failure; Sars-CoV2
NCT04479267

Recruiting

Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Double or Triple Hit Lymphoma

Conditions: Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2 and BCL6 Rearrangements
NCT04477200

Not yet recruiting

Mycophenolate Mofetil Combined With Radiation Therapy in Recurrent Glioblastoma

Conditions: Recurrent Glioblastoma; Recurrent Gliosarcoma
NCT04473911

Not yet recruiting

Haplo Peripheral Blood Sct In GVHD Prevention

Conditions: GVHD; AML; ALL; MDS; MPN; CMML; Hodgkin Lymphoma; Non Hodgkin Lymphoma; Blood Stem Cell Transplant Failure; Graft Vs Host Disease; Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndromes; Myeloproliferative Disorder; Chronic Myelomonocytic Leukemia; Chemosensitive Hodgkin Lymphoma
NCT04473924

Not yet recruiting

Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk

Conditions: Infection; Transplant;Failure,Kidney
NCT04471441

Recruiting

Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients.

Conditions: Liver Transplant
NCT04469530

Not yet recruiting

Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors

Conditions: Solid Tumor
NCT04469842

Not yet recruiting

Early Use of Long-acting Tacrolimus in Lung Transplant Recipients

Conditions: Lung Transplant; Complications
NCT04470804

Not yet recruiting

Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA

Conditions: Pure Red Cell Aplasia, Acquired
NCT04463901

Recruiting

Conjunctival Autograft or Limbal Conjunctival Autograft for Recurrent Pterygium Using Mitomycin C

Conditions: Recurrent Pterygium
NCT04460820

Completed

A Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection

Conditions: Bioequivalence
NCT04461340

Not yet recruiting

Efficacy and Safety of Sirolimus in COVID-19 Infection

Conditions: COVID 19
NCT04448873

Recruiting

Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma

Conditions: Kaposiform Hemangioendothelioma; Kasabach-Merritt Syndrome
NCT04447027

Not yet recruiting

A Phase 1 Study of Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies

Conditions: Relapsed/Refractory T-cell Malignancies; Cutaneous T-Cell Lymphoma; Mature T-cell Malignancies; Peripheral T-Cell Lymphoma
NCT04444843

Not yet recruiting

Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive Regimen

Conditions: Kidney Transplant Recipients
NCT04443348

Not yet recruiting

Pre-op Pembro + Radiation Therapy in Breast Cancer

Conditions: Triple Negative Breast Cancer; Hormone Receptor Positive (HR+), HER2-negative Breast Cancer; Biopsy-proven, Positive Lymph Node(s)
NCT04440267

Not yet recruiting

Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage

Conditions: Acute Leukemia of Ambiguous Lineage
NCT04437160

Recruiting

Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy

Conditions: Triple Negative Breast Cancer
NCT04432714

Recruiting

Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement

Conditions: DLBCL; Untreated; MYC Gene Rearrangement
NCT04433156

Recruiting

VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma

Conditions: Marginal Zone Lymphoma
NCT04433572

Not yet recruiting

Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee

Conditions: Peripheral Artery Disease; Critical Limb Ischemia
NCT04424862

Not yet recruiting

Multitarget Therapy for Idiopathic Membranous Nephropathy

Conditions: Efficacy
NCT04423926

Recruiting

Lenalidomide in Combination With CHOP in Patients With Untreated PTCL

Conditions: PTCL, NOS; AITL; ALK- ALCL; Phase III-IV ALK+ ALCL; EATL
NCT04417920

Completed

Express Implant Versus Trabeculectomy After Late Failure Trabeculectomy

Conditions: Glaucoma
NCT04418154

Recruiting

Neoadjuvant Dose-dense EC Followed by ABX With PD-1 for Triple Negative Breast Cancer Patients

Conditions: Triple Negative Breast Cancer
NCT04419038

Completed

Evaluation of Conjunctival Autografting With MMC Application Versus Ologen Implantation of Recurrent Pterygium

Conditions: Recurrent Pterygium of Eye
NCT04415476

Not yet recruiting

Standard Therapy Using Tacrolimus, Mycophenolate Mofetil and Prednisone For Chronic Lung Transplant Rejection (BOS)

Conditions: Disorder Related to Lung Transplantation; Chronic Rejection of Lung Transplant; Decreased Immunologic Activity
NCT04409691

Not yet recruiting

SCMC Trial on KHE With KMP (V.2020)

Conditions: Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)
NCT04409912

Not yet recruiting

Sirolimus Coated Angioplasty Versus Plain Balloon Angioplasty

Conditions: End Stage Renal Failure on Dialysis; Arteriovenous Graft Occlusion
NCT04406870

Not yet recruiting

Sirolimus in the Treatment for Infantile Hepatic Hemangioendothelioma(IEEH)

Conditions: Hemangioendothelioma of Liver
NCT04402580

Recruiting

Efficacy of Anti-CD20 Antibodies (Rituximab Biosimilar) in the Treatment of Childhood Steroid-dependent Nephrotic Syndrome

Conditions: Nephrotic Syndrome Steroid-Dependent
NCT04402723

Recruiting

Combination of Donafenib and Cytarabine/Daunorubicin in Relapsed AML

Conditions: Acute Myeloid Leukemia (AML)
NCT04393454

Not yet recruiting

Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy

Conditions: Metastatic dMMR Solid Cancer; Solid Tumor; Cancer; Metastatic Solid Tumor
NCT04388839

Not yet recruiting

Evolutionary Therapy for Rhabdomyosarcoma

Conditions: Rhabdomyosarcoma
NCT04383743

Not yet recruiting

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

Conditions: Stage II Bladder Cancer AJCC v8; Stage IIIA Bladder Cancer AJCC v8
NCT04384692

Not yet recruiting

Ruxolitinib for the Treatment of Graft Versus Host Disease Following Stem Cell Transplant in Patients With Primary and Secondary Myelofibrosis

Conditions: Primary Myelofibrosis; Secondary Myelofibrosis
NCT04385290

Not yet recruiting

Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)

Conditions: Acute Myeloid Leukemia
NCT04376528

Not yet recruiting

Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy

Conditions: Hepatitis, Autoimmune; Primary Biliary Cholangitis; Immunosuppression
NCT04374903

Not yet recruiting

Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients

Conditions: COVID-19 Patients
NCT04375631

Not yet recruiting

CLAG-M Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Conditions: Recurrent Acute Myeloid Leukemia; Recurrent Chronic Myelomonocytic Leukemia; Recurrent Myelodysplastic Syndrome; Refractory Acute Myeloid Leukemia; Refractory Chronic Myelomonocytic Leukemia; Refractory Mixed Phenotype Acute Leukemia; Refractory Myelodysplastic Syndrome; Refractory Acute Leukemia of Ambiguous Lineage; Refractory Acute Undifferentiated Leukemia
NCT04375813

Recruiting

Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention

Conditions: Non-muscle Invasive Bladder Cancer
NCT04370795

Enrolling by invitation

Matched Related and Unrelated Donor Stem Cell Transplantation for Severe Combined Immune Deficiency (SCID): Busulfan-based Conditioning With h-ATG, Radiation, and Sirolimus

Conditions: Severe Combined Immunodeficiency (SCID)
NCT04371640

Recruiting

Sirolimus in COVID-19 Phase 1

Conditions: SARS-CoV-2; Covid-19
NCT04370301

Not yet recruiting

Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

Conditions: Primary Myelofibrosis; Secondary Myelofibrosis
NCT04368091

Active, not recruiting

Clinical Use and Safety of the Xtreme Touch (Magic Touch PTA)- Neo Sirolimus Coated PTA Balloon Catheter in the Treatment of Infrainguinal Peripheral Arterial Disease

Conditions: Peripheral Artery Disease; Atherosclerosis